Bharat Biotech had approached the Indian Institute of Chemical Technology to develop the synthetic route for the adjuvant molecule TLR 7/8 with indigenous chemicals at an affordable price and with highest purity.
The Indian Institute of Chemical Technology (IICT), a Council for Scientific and Industrial Research (CSIR) lab here, played a role in the development of Covaxin, the indigenous vaccine developed by city-based Bharat Biotech International Limited